Eli Lilly and Company v. Perrigo Company

  1. November 22, 2017

    Fed. Circ. OKs Ax Of Lilly's Axiron Patent, Allows Generics

    The Federal Circuit ruled Wednesday that a key claim of an Eli Lilly & Co. patent on the testosterone drug Axiron is invalid, upholding a lower court ruling that spurred the generics makers accused of infringement to launch their own versions of the drug.

  2. October 05, 2017

    Fed. Circ. Judge Recoils At Cesspool Remark In Axiron Suit

    An Eli Lilly & Co. lawyer's description of the adult male armpit as a "cesspool" of sweat, hair and bacteria during a high-stakes patent case over the testosterone drug Axiron proved a bit too graphic for Federal Circuit Judge S. Jay Plager during oral arguments Thursday, who told the attorney: "You don't have to be quite so nasty."